July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

05/25/23 Crapo Statement on Ways and Means Republicans’ Defending American Jobs and Investment Act
05/18/23 Crapo Statement at Hearing on Tax Incentives in the Inflation Reduction Act
05/16/23 Crapo Statement on IRS Direct File Pilot Project
05/11/23 Senate Republicans Introduce Legislation to Recover Hundreds of Billions in Unchecked Unemployment Fraud
05/11/23 Crapo Statement at Hearing on International Tax Policy